文献速递复苏、休克与脓毒症

院外心脏骤停中骨髓腔内与静脉通路比较:一项随机临床试验的贝叶斯二次分析

Intraosseous vs. intravenous access during out-of-hospital cardiac arrest: a Bayesian secondary analysis of a randomised clinical trial.
PubMed 文献 · Resuscitation · 2025-05-17
一句话结论在成人非创伤性院外心脏骤停中,骨髓腔内与静脉通路在自主循环恢复方面存在临床意义差异的概率很低,30天结局不确定,无强证据支持任一方法。

本研究为IVIO随机试验的贝叶斯二次分析,比较骨髓腔内与静脉通路在1479例成人非创伤性院外心脏骤停患者中的应用。采用无信息先验时,两种通路在自主循环恢复方面效应超过假设差异的后验概率分别为1.2%(风险比>1.27,支持骨髓腔内)和<0.1%(风险比<0.79,支持静脉)。对于30天生存及30天神经功能良好生存,骨髓腔内相比静脉的风险比落在0.83至1.2之间的后验概率分别为58%和55%。采用信息先验时,所有分析均未提供强烈支持任一通路的后验概率。结论认为自主循环恢复方面临床意义差异的概率很低,30天结局不确定。

要点

  • 在1479例成人非创伤性院外心脏骤停中,无信息先验下骨髓腔内通路在自主循环恢复方面效应超过假设差异(风险比>1.27)的后验概率仅1.2%。
  • 静脉通路在自主循环恢复方面效应超过假设差异(风险比<0.79)的后验概率<0.1%。
  • 骨髓腔内相比静脉通路,30天生存的风险比落在0.83至1.2之间的后验概率为58%。
  • 骨髓腔内相比静脉通路,30天神经功能良好生存的风险比落在0.83至1.2之间的后验概率为55%。
  • 采用信息先验时,所有分析均未提供强烈支持骨髓腔内或静脉通路的概率。

适用人群与场景

  • 成人非创伤性院外心脏骤停患者,共1479例。

研究设计与关键结果

  • 研究类型:随机临床试验(IVIO试验)的贝叶斯二次分析,样本量1479例成人非创伤性院外心脏骤停患者,比较骨髓腔内与静脉通路。
  • 主要终点:无信息先验下,自主循环恢复效应超过假设差异的后验概率为1.2%(风险比>1.27,支持骨髓腔内)和<0.1%(风险比<0.79,支持静脉)。
  • 关键次要终点:30天生存和30天神经功能良好生存,骨髓腔内相比静脉的风险比落在0.83至1.2之间的后验概率分别为58%和55%。
  • 采用信息先验时,所有分析均未提供强烈支持骨髓腔内或静脉通路的概率。

证据类型、等级与局限

  • 证据类型:随机临床试验的贝叶斯二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在成人非创伤性院外心脏骤停中,骨髓腔内与静脉通路在自主循环恢复方面存在临床意义差异的概率很低,30天结局不确定,无强证据支持任一方法。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIM OF THE STUDY: This study aimed to apply a Bayesian probabilistic framework to the Intravenous vs. Intraosseous Vascular Access for Out-of-Hospital Cardiac Arrest (IVIO) trial data to evaluate the likelihood of benefit for each vascular access method while incorporating various prior beliefs.

METHODS: The IVIO trial was a randomised trial comparing intraosseous to intravenous access in 1,479 adults with non-traumatic out-of-hospital cardiac arrest. Bayesian analyses were pre-planned in the protocol and conducted using both non-informative and informative priors to calculate posterior probabilities for sustained return of spontaneous circulation, 30-day survival, and 30-day survival with a favourable neurologic outcome.

RESULTS: Using non-informative priors for return of spontaneous circulation, the posterior probabilities that the effect of either vascular access exceeds the hypothesised difference were 1.2% (risk ratio > 1.27, favouring intraosseous access) and < 0.1% (risk ratio < 0.79 [1/1.27], favouring intravenous access). For 30-day survival and survival with a favourable neurologic outcome, the posterior probability that the risk ratio for intraosseous compared to intravenous access is between 0.83 (1/1.2) and 1.2 was 58% and 55%, respectively. For all analyses with informative priors, the results did not provide probabilities strongly favouring either intraosseous or intravenous access.

CONCLUSIONS: The probability of a clinically meaningful difference in return of spontaneous circulation between intraosseous and intravenous access for out-of-hospital cardiac arrest was very low, while results for 30-day outcomes were uncertain, with no strong evidence favouring either method.

TRIAL REGISTRATION: EU Clinical Trials number: 2022-500744-38-00.

CLINICALTRIALS: gov number: NCT05205031.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Vallentin MF, Holmberg MJ, Granfeldt A, et al. Intraosseous vs. intravenous access during out-of-hospital cardiac arrest: a Bayesian secondary analysis of a randomised clinical trial. Resuscitation. 2025. PMID: 40348355. doi:10.1016/j.resuscitation.2025.110634

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。